Express News | Brainstorm Cell Therapeutics to Provide Corporate Mid-Year Update on Nurown Program

BreakingsJul 1 18:00

Brainstorm Cell Therptcs Entered Into Securities Purchase Agreement With a Single Institutional Investor >BCLI

Dow JonesJun 27 21:16

Express News | Brainstorm Cell Therapeutics Announces Pricing of $4.0 Million Registered Direct Offering

BreakingsJun 27 21:15

Express News | Brainstorm Cell Therapeutics Inc - Alignment With FDA on Nur Own Cmc Aspects

BreakingsJun 26 20:00

Express News | Brainstorm Cell Therapeutics Reaches Alignment With FDA on Cmc Aspects of Phase 3B Nurown® Clinical Trial

BreakingsJun 26 20:00

BrainStorm Appoints Haro Hartounian as COO

Seeking AlphaJun 20 18:29